Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGESELSKABET ØSTBYENS ØJENKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   5.8% 5.3% 7.1% 6.6% 7.2% 4.4% 16.9% 16.6%   Credit score (0-100)   41 43 34 35 33 46 10 11   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,621 2,391 2,313 2,369 2,320 2,285 0.0 0.0   EBITDA   1,002 882 628 895 984 942 0.0 0.0   EBIT   150 179 -32.9 414 819 922 0.0 0.0   Pre-tax profit (PTP)   21.3 40.7 -141.3 328.3 762.7 905.7 0.0 0.0   Net earnings   16.2 31.3 -110.6 255.8 594.4 705.0 0.0 0.0   Pre-tax profit without non-rec. items   21.3 40.7 -141 328 763 906 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,235 847 501 177 12.2 68.0 0.0 0.0   Shareholders equity total   -1,155 -1,124 -1,235 -979 -384 321 271 271   Interest-bearing liabilities   3,276 2,507 2,012 1,304 715 31.9 0.0 0.0   Balance sheet total (assets)   2,555 1,842 1,242 819 677 737 271 271   Net Debt   3,102 2,245 1,717 972 375 -134 -271 -271     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,621 2,391 2,313 2,369 2,320 2,285 0.0 0.0   Gross profit growth   1.7% -8.7% -3.3% 2.4% -2.1% -1.5% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% -16.7% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,555 1,842 1,242 819 677 737 271 271   Balance sheet change%   -24.6% -27.9% -32.6% -34.1% -17.3% 9.0% -63.3% 0.0%   Added value   1,002.1 881.6 628.5 895.5 1,300.6 942.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,705 -1,406 -1,323 -963 -330 36 -68 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.7% 7.5% -1.4% 17.5% 35.3% 40.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.6% 5.4% -1.2% 19.4% 57.3% 102.6% 0.0% 0.0%   ROI %   3.9% 5.9% -1.4% 24.2% 81.1% 172.9% 0.0% 0.0%   ROE %   0.5% 1.4% -7.2% 24.8% 79.5% 141.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -31.1% -37.9% -49.8% -54.4% -36.2% 43.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   309.5% 254.6% 273.2% 108.6% 38.1% -14.2% 0.0% 0.0%   Gearing %   -283.6% -223.1% -163.0% -133.2% -185.9% 10.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.5% 4.8% 4.8% 5.2% 5.6% 4.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 1.3 1.4 1.2 1.7 1.0 0.0 0.0   Current Ratio   0.1 1.3 1.4 1.2 1.7 1.0 0.0 0.0   Cash and cash equivalent   173.9 262.4 294.9 331.5 339.5 165.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,100.5 111.5 160.8 91.5 256.6 -5.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   418 441 314 448 650 471 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   418 441 314 448 492 471 0 0   EBIT / employee   62 89 -16 207 409 461 0 0   Net earnings / employee   7 16 -55 128 297 352 0 0